Table 2.
Variables | Category | Univariate analysis | Multivariate analysis | ||||||
---|---|---|---|---|---|---|---|---|---|
OR | OR (95% CI) | p value | OR | OR (95% CI) | p value | ||||
Sex | Male | 1.416 | 0.488 | 4.111 | 0.522 | ||||
Age | >60 years | 0.471 | 0.144 | 1.54 | 0.213 | ||||
Site | Right | 2.523 | 0.877 | 7.257 | 0.086 | ||||
Lynch syndrome | Yes | 1.596 | 0.548 | 4.65 | 0.392 | ||||
Liver metastasis | Yes | 0.55 | 0.187 | 1.619 | 0.278 | ||||
Lung metastasis | Yes | 1.214 | 0.23 | 6.421 | 0.819 | ||||
Immunotherapy type | Anti-PD1 + anti-CALT4 | 0.481 | 0.074 | 3.124 | 0.443 | ||||
Chemotherapy | Yes | 2.526 | 0.652 | 9.791 | 0.18 | ||||
Anti-angiogenesis | Yes | 1.848 | 0.367 | 9.308 | 0.457 | ||||
Line | ≥2 | 0.55 | 0.187 | 1.619 | 0.278 | ||||
CRP | High | 0.481 | 0.097 | 2.4 | 0.372 | ||||
CHO | High | 0.407 | 0.138 | 1.194 | 0.102 | ||||
HDLC | High | 4.017 | 1.270 | 12.708 | 0.018 | 4.709 | 1.415 | 15.666 | 0.012 |
ALT | High | 0.322 | 0.066 | 1.561 | 0.159 | ||||
AST | High | 0.336 | 0.113 | 1.003 | 0.051 | ||||
PNI | High | 5.1 | 1.07 | 24.315 | 0.041 | 0.162 | 0.032 | 0.815 | 0.027 |
LCR | High | 1.109 | 0.387 | 3.176 | 0.847 | ||||
SII | High | 0.654 | 0.11 | 3.891 | 0.641 |